Lexicon Pharmaceuticals surges as Cantor Fitzgerald sees unencumbered path in HCM

🇺🇸 Investing.com (US) —
Lexicon Pharmaceuticals surges as Cantor Fitzgerald sees unencumbered path in HCM

AI Summary

Lexicon Pharmaceuticals shares surged after Cantor Fitzgerald cited an unencumbered path in hypertrophic cardiomyopathy (HCM). The headline suggests a favorable analyst view of the company’s prospects in this therapeutic area, but provides no further detail.

Markets Health Lexicon Pharmaceuticals Cantor Fitzgerald stock surge hypertrophic cardiomyopathy analyst outlook

Read original source →